5 insiders reported 71 Form 4 transactions for Relay Therapeutics, Inc. (RLAY) over the past 18 months (most recent 2026-08-18). Recent activity: Patel Sanjiv (President and CEO) Sell 48,199 shares, Catinazzo Thomas (Chief Financial Officer) Sell 17,717 shares, Rahmer Peter (See remarks) Sell 748 shares, Bergstrom Donald A (President, R&D) Sell 2,237 shares, Catinazzo Thomas (Chief Financial Officer) Sell 1,459 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Patel Sanjiv | President and CEO | Sell | 48,199 | $979,886 |
| 2026-08-18 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | $349,734 |
| 2026-07-30 | Rahmer Peter | See remarks | Sell | 748 | $13,920 |
| 2026-07-30 | Bergstrom Donald A | President, R&D | Sell | 2,237 | $41,631 |
| 2026-07-30 | Catinazzo Thomas | Chief Financial Officer | Sell | 1,459 | $27,152 |
| 2026-07-08 | Bergstrom Donald A | President, R&D | Sell | 8,660 | $162,029 |
| 2026-07-08 | Patel Sanjiv | President and CEO | Buy | 3,056 | $21,239 |
| 2026-07-08 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | $331,131 |
| 2026-07-08 | Patel Sanjiv | President and CEO | Sell | 48,199 | $943,736 |
| 2026-07-02 | Rahmer Peter | See remarks | Sell | 50,000 | $954,500 |
| 2026-07-02 | Rahmer Peter | See remarks | Buy | 3,056 | $21,239 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Sell | 61,563 | $1.0M |
| 2026-06-24 | Bergstrom Donald A | President, R&D | Buy | 93,456 | $385,039 |
| 2026-06-24 | Bergstrom Donald A | President, R&D | Sell | 93,456 | $1.6M |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Buy | 56,323 | $283,868 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Sell | 56,323 | $955,801 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Buy | 61,563 | $321,359 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | $301,366 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Buy | 51,560 | $229,442 |
| 2026-06-24 | Catinazzo Thomas | Chief Financial Officer | Sell | 51,560 | $874,973 |
| 2026-05-14 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | $227,841 |
| 2026-04-30 | Bergstrom Donald A | President, R&D | Sell | 1,490 | $22,037 |
| 2026-04-30 | Catinazzo Thomas | Chief Financial Officer | Sell | 972 | $14,376 |
| 2026-04-30 | Rahmer Peter | See remarks | Sell | 753 | $11,137 |
| 2026-04-09 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | $230,498 |
Source: SEC Form 4 filings · as of 2026-08-18